We recently published a list of 10 Worst Blue Chip Stocks to Buy. In this article, we are going to take a look at where Merck ...

Shares fell after the company cut its full-year guidance on the back of challenging macroeconomic conditions and ...

Merck (MRK) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...

While Merck's shares declined by 3% over the last month, this shift aligns with the flat market performance, ...

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

The healthcare bellwether’s performance has been solid ... Let's delve deeper to understand whether to buy, sell or hold Merck stock. Merck’s stock has declined 21.1% so far this year compared ...

Merck (MRK) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Shares of Merck & Co. Inc. MRK slid 1.86% to $77.65 Thursday, on what proved to be an all-around positive trading session for ...

This strong performance was fueled by consistent sales ... After the earnings announcement on Friday, April 25th, Merck’s (MRK) stock price rose by 4%. However, year-to-date, MRK stock has ...